𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

✍ Scribed by Schoemaker, N E; Kuppens, I E L M; Moiseyenko, V; Glimelius, B; Kjaer, M; Starkhammer, H; Richel, D J; Smaaland, R; Bertelsen, K; Poulsen, J P; Voznyi, E; Norum, J; Fennelly, D; Tveit, K M; Garin, A; Gruia, G; Mourier, A; Sibaud, D; Lefebvre, P; Beijnen, J H; Schellens, J H M; ten Bokkel Huinink, W W


Book ID
109998279
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
123 KB
Volume
91
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A multicenter, Phase II trial of weekly
✍ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 2 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9